Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Completed

Conditions studied: Anxiety Disorder, Breast Cancer, Depression, Psychosocial Effects of Cancer and Its Treatment

In brief

RATIONALE: Gathering information about how patients respond to stress and measuring stress levels in women with newly diagnosed breast cancer may help doctors provide better methods of treatment and on-going care. PURPOSE: This research study is measuring stress in women with newly diagnosed stage I, stage II, or stage III breast cancer or ductal carcinoma in situ of the breast.

Key facts

Study ID

NCT00665782

Run by

Wake Forest University Health Sciences

People needed

24

Starts

2008-03-01

Expected to finish

2010-07-01

Last updated by the study team

2018-07-03

Who can join

Age: 18 and older, up to 120. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with stage I-III invasive breast cancer or ductal carcinoma in situ of the breast within the past 2 weeks
• Surgery for breast cancer planned
• Hormone receptor status not specified
• Female
• Menopausal status not specified
• Able to refrain from:
• Smoking cigarettes for the 24-hour period of saliva-sample collection
• Brushing teeth or eating for up to one hour prior to saliva collection
• More than 1 year since prior therapy for another malignancy
• At least 1 month since prior withdrawal from hormone-replacement product
• Able to refrain from steroid inhalers for greater than 24 hours
• No chronic oral steroids

Where it is running

• Wake Forest University Comprehensive Cancer Center — Winston-Salem, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.